Glaxosmithkline Pharmaceuticals Ltd. Share Price

Overview

Glaxosmithkline Pharmaceuticals Ltd. share price is currently ₹2,803.17, down by - ₹33.91 (1.2%) from its previous closing price of ₹2,837.08. The share price has declined -1.51% over the past month and gained 0.21% over the past year. The stock's 52-week low and high are ₹2,048.50 and ₹3,092.46, respectively. Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of ₹ 47,910.00 Cr. The share price was last updated on 17 Sep 2026, 12:20 PM IST.

Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Pharmaceuticals Ltd.
GLAXO
 0.00
- 33.91
1.20%
Healthcare
 0.00(%)1D

Updated: 17 Sep 2026, 12:20:02 pm IST

Market Data

Open Price

 2,829.49

Prev. Close

 2,837.08
 2,802.74

Day Low

 2,835.67

Day High

 2,048.50

52 Week Low

 3,092.46

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

44.46

Sector PE

44.64

PB Ratio

20.80

Sector PB

5.99

EPS

63.05

Dividend Yield

2.50

Today's Volume

4.609 K

5 Day Avg. Volume

41.128 K

PEG Ratio

3.80

Market Cap.

₹ 47,910.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 570% at ₹57/Share
29-May-202629-May-2026
DividendsFinal Dividend of 420% at ₹42/Share
30-May-202530-May-2025
DividendsInterim Dividend of 120% at ₹12/Share
07-Nov-202407-Nov-2024

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
SBI Midcap Fund - Regular Plan - Growth12.00 Lac
11.80 Lac
(1.67%)
Kotak Large & Mid Cap Fund - Growth-
11.00 Lac
(100%)
Nippon India Pharma Fund - Growth9.29 Lac
10.29 Lac
(10.83%)
Quant Mid Cap Fund - Growth1.01 Lac
7.74 Lac
(666.55%)
Nippon India Growth Mid Cap Fund - Growth Option5.59 Lac
5.59 Lac
no change

About Glaxosmithkline Pharmaceuticals Ltd. 👋

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Unite Technologies Financial

Unite Technologies Financial

30 Aug • 11:04 PM · SEBI-Registered Analyst

GlaxoSmithKline – Technical View, demand and supply

The stock

GLAXO
is trading around ₹3106.4 on the daily chart. The stock has shown a strong recovery from the ₹2100–₹2200 zone and has recently accelerated upward with strong price momentum. The daily structure has turned strongly bullish with higher highs and higher lows visible from the June low. The sharp move from around ₹2600 towards ₹3100 indicates strong buying momentum. Immediate resistance is around ₹3100–₹3200 followed by the previous high zone near ₹3400. On the downside ₹2900–₹3000 is the immediate support zone while ₹2600–₹2700 is the next important support area. Short-term buyers should watch the ₹3100–₹3200 zone for sustained strength. Holders can monitor the current higher-high and higher-low structure. A sustained move above ₹3200 would keep the current bullish momentum intact while a breakdown below ₹2900–₹3000 would indicate weakness.

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

19 Aug • 10:34 PM · SEBI-Registered Analyst

High delivery stock

Symbol Delivered Qty ASTERDM 62324493 APOLLOTYRE 1551426 RAILTEL 1004625 ATGL 1378460 HSCL 7592497 AIIL 443706 JUBLPHARMA 712444 GLAXO 438502 SWIGGY 8661820 PFIZER 111827 SOBHA 109386 IGL 1962541 PFOCUS 884325 AADHARHFC 670510

ASTERDM

See More
PATEL ABHIKUMAR HARESHBHAI

PATEL ABHIKUMAR HARESHBHAI

22 Jul • 4:31 PM · SEBI-Registered Analyst

Daily Index View : NIFTY50 as on 22/07/2026

1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 -5% 🔍 Key Level to Watch: 24189 🔄 Current Market Surface: The trend will stay Positive until the market stay above 24189 That’s 1 points away from the last day Closing Price of 24188 ATR 363 2. Demand & Supply PROBABILITY Force is Demand & Supply is High -15% Last 3 days market has been flatish on downside compared to ATR, so supply has very strong firepower — it just needs sentiment support 21 Jul 2026 FII Cash-net (Buy/sell) DII Cash- net (BUY/SELL) +1,650.16 -657 3. Reflexivity PROBABILITY First Half is Mildly Supportive to Bearish Momentum for at least first half -5% Last day market fell Intraday around 25–50% of the 8-day average ATR, so downside momentum should remain intact in the first half 4. Social Proof (Global) PROBABILITY Dow Jones (Last day close) 48185 Up/Donw by 308 -17% Dow jones future (live) 52,399 Up/Donw by -44 Hang seng (Live) 25132 Up/Donw by -240 Nikki 225 (Live) 66116 Up/Donw by -117 Sentiments: Dow Jones Futures is Trading Flat to Negative & HANG SENG Index is trading Negative Today, global markets are neutral to slightly positive, and the Indian market has no strong directional bias Top stock to watchout

GLAXO

See More
Harsh Vardhan

Harsh Vardhan

2 Jul • 11:38 PM · SEBI-Registered Analyst

GLAXO
GlaxoSmithKline Pharmaceuticals: Backed by Strong Brands and Healthcare Demand

GLAXO
GlaxoSmithKline Pharmaceuticals Limited is a leading pharmaceutical company with a strong portfolio of prescription medicines and vaccines across therapeutic areas such as respiratory, anti-infectives, dermatology and oncology. The company benefits from trusted global brands, strong parentage, an established distribution network and rising healthcare spending in India. Continued focus on innovation, specialty therapies and preventive healthcare supports long-term growth. Key Financials: Revenue: ~₹3,800+ Cr | Net Profit: ~₹700+ Cr | EBITDA Margin: ~24–26% | ROE: ~20%+ | Debt: Virtually debt-free | Strong Cash Generation. Key Positives: Leading portfolio of established pharmaceutical brands, strong presence in vaccines and specialty medicines, healthy margins, robust cash flows, low debt and beneficiary of rising healthcare awareness and pharmaceutical demand. Conclusion: With strong brand equity, a healthy balance sheet and exposure to India's growing healthcare market, GlaxoSmithKline Pharmaceuticals is well positioned to deliver stable earnings growth and long-term shareholder value.

See More
Akshay Patel

Akshay Patel

2 Jun • 2:52 PM · SEBI-Registered Analyst

GLAXO
has recommended a dividend of ₹57 per share for FY26, payable on or after June 30, 2026, to shareholders on record as of May 29, 2026. The 101st AGM is set for June 30, 2026, via video conferencing. Dividend payments will be made electronically only. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.

See More
Vimal K

Vimal K

28 May • 9:33 AM · SEBI-Registered Analyst

WATCH OUT FOR CORPORATE ACTIONS

Watch out for the Corporate actions today 29-May-2026 on the below mentioned stocks: - Life Insurance Corporation of India (LIC) : - Life Insurance Corporation of India 1:1 Bonus Issue (Investors receive 1 free additional share for every 1 share held). The Ex-Date and Record Date are both fixed for May 29, 2026. Bajaj Auto Ltd, GlaxoSmithKline Pharma, Torrent Pharmaceuticals, ERIS Lifesciences Ltd, ICICI Lombard GI, Home First Finance, and Bank of India will trade Ex-Dividend tomorrow the 29-May-2026.

BAJAJ-AUTO
TORNTPHARM
ERIS
ICICIGI
HOMEFIRST
BANKINDIA

See More

News & Events

Frequently Asked Questions

What is the share price of Glaxosmithkline Pharmaceuticals Ltd.?

What is the market cap of Glaxosmithkline Pharmaceuticals Ltd.?

Should I buy Glaxosmithkline Pharmaceuticals Ltd. stock now?

What is the 52 week high and low of Glaxosmithkline Pharmaceuticals Ltd.?

Is the Glaxosmithkline Pharmaceuticals Ltd. stock good to buy?

Is Glaxosmithkline Pharmaceuticals Ltd. a good buy for the long term?

Is Glaxosmithkline Pharmaceuticals Ltd. overvalued or undervalued?

What is the PE and PB ratio of Glaxosmithkline Pharmaceuticals Ltd.?

Start Now